Cargando…

Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression

Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. Its incidence has grown alongside the increasing global prevalence of type 2 diabetes, obesity, and metabolic syndrome. The risk of progression to hepatocellular carcinoma for nonalcoholic steatohep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thandra, Krishna Chaitanya, Barsouk, Adam, Saginala, Kalyan, Aluru, John Sukumar, Rawla, Prashanth, Barsouk, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816638/ https://www.ncbi.nlm.nih.gov/pubmed/33511275 http://dx.doi.org/10.5114/ceh.2020.102153

Ejemplares similares

Epidemiology of lung cancer
por: Thandra, Krishna Chaitanya, et al.
Publicado: (2021)

Chemical Risk Factors of Primary Liver Cancer: An Update
por: Barsouk, Adam, et al.
Publicado: (2021)

Epidemiology of Melanoma
por: Saginala, Kalyan, et al.
Publicado: (2021)

Epidemiology, Risk Factors, and Prevention of Head and Neck Squamous Cell Carcinoma
por: Barsouk, Adam, et al.
Publicado: (2023)

Valvular Heart Disease Epidemiology
por: Aluru, John Sukumar, et al.
Publicado: (2022)

Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
por: Barsouk, Adam, et al.
Publicado: (2021)

Epidemiology of Bladder Cancer
por: Saginala, Kalyan, et al.
Publicado: (2020)

Epidemiology of Renal Cell Carcinoma
por: Padala, Sandeep Anand, et al.
Publicado: (2020)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

US Cancer Screening Recommendations: Developments and the Impact of COVID-19
por: Barsouk, Adam, et al.
Publicado: (2022)

Epidemiology, Staging and Management of Prostate Cancer
por: Barsouk, Adam, et al.
Publicado: (2020)

Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention
por: Barsouk, Adam, et al.
Publicado: (2019)

Epidemiology of gallbladder cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Targeted Therapies and Immunotherapies in the Treatment of Esophageal Cancers
por: Barsouk, Adam, et al.
Publicado: (2019)

Epidemiology of gastric cancer: global trends, risk factors and prevention
por: Rawla, Prashanth, et al.
Publicado: (2018)

Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors
por: Rawla, Prashanth, et al.
Publicado: (2019)

Immunotherapies and Targeted Therapies in the Treatment of Metastatic Colorectal Cancer
por: Rawla, Prashanth, et al.
Publicado: (2019)

Epidemiology, Staging, and Management of Multiple Myeloma
por: Padala, Sandeep Anand, et al.
Publicado: (2021)

A Systematic Review of the Extra-Hepatic Manifestations of Hepatitis E Virus Infection
por: Rawla, Prashanth, et al.
Publicado: (2020)

Efficacy and safety of megestrol in the management of hepatocellular carcinoma: a systematic review of the literature
por: Rawla, Prashanth, et al.
Publicado: (2018)

Systematic review and case report: Systemic lupus erythematosus with renal tubular acidosis
por: Rawla, Prashanth, et al.
Publicado: (2020)

Efficacy and Safety of Budesonide in the Treatment of Eosinophilic Esophagitis: Updated Systematic Review and Meta-Analysis of Randomized and Non-Randomized Studies
por: Rawla, Prashanth, et al.
Publicado: (2018)

Superior Mesenteric Vein Thrombosis in a Patient on Oral Contraceptive Pills
por: Rawla, Prashanth, et al.
Publicado: (2017)

Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Younossi, Zobair M., et al.
Publicado: (2021)

Epidemiology of Prostate Cancer
por: Rawla, Prashanth
Publicado: (2019)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention
por: Baffy, György
Publicado: (2013)

Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications
por: Wong, Sui‐Weng, et al.
Publicado: (2018)

Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach
por: Grgurevic, Ivica, et al.
Publicado: (2021)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
por: Teng, Yu-Xian, et al.
Publicado: (2022)

Update in global trends and aetiology of hepatocellular carcinoma
por: Rawla, Prashanth, et al.
Publicado: (2018)

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
por: Rawla, Prashanth, et al.
Publicado: (2019)

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
por: Wong, Carrie R, et al.
Publicado: (2016)

Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Said, Adnan, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease-related hepatocellular carcinoma
por: Daher, Darine, et al.
Publicado: (2023)

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Colon Carcinoma Presenting as Streptococcus anginosus Bacteremia and Liver Abscess
por: Rawla, Prashanth, et al.
Publicado: (2017)

Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
por: Martínez-Domínguez, Samuel J., et al.
Publicado: (2023)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Stice, Camilla P., et al.
Publicado: (2018)

Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern
por: Dhamija, Ekta, et al.
Publicado: (2019)

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease
por: Cai, Changzhou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2csrqq1pja8inajaneokoqcj97